Veradigm Total Liabilities 2010-2022 | MDRX
Veradigm total liabilities from 2010 to 2022. Total liabilities can be defined as the total value of all possible claims against the corporation.
| Veradigm Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2022 | $487 |
| 2021 | $951 |
| 2020 | $1,251 |
| 2019 | $1,921 |
| 2018 | $1,601 |
| 2017 | $3,070 |
| 2016 | $2,559 |
| 2015 | $1,263 |
| 2014 | $1,180 |
| 2013 | $1,302 |
| 2012 | $1,065 |
| 2011 | $1,027 |
| 2010 | $1,035 |
| 2010 | $288 |
| 2009 | $252 |
| Veradigm Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2022-12-31 | $487 |
| 2022-09-30 | $514 |
| 2022-06-30 | $518 |
| 2022-03-31 | $1,077 |
| 2021-12-31 | $951 |
| 2021-09-30 | $1,066 |
| 2021-06-30 | $1,147 |
| 2021-03-31 | $1,193 |
| 2020-12-31 | $1,251 |
| 2020-09-30 | $1,938 |
| 2020-06-30 | $1,946 |
| 2020-03-31 | $2,011 |
| 2019-12-31 | $1,921 |
| 2019-09-30 | $1,949 |
| 2019-06-30 | $1,919 |
| 2019-03-31 | $1,786 |
| 2018-12-31 | $1,601 |
| 2018-09-30 | $3,401 |
| 2018-06-30 | $3,212 |
| 2018-03-31 | $3,260 |
| 2017-12-31 | $3,070 |
| 2017-09-30 | $2,737 |
| 2017-06-30 | $2,619 |
| 2017-03-31 | $2,610 |
| 2016-12-31 | $2,559 |
| 2016-09-30 | $2,440 |
| 2016-06-30 | $2,359 |
| 2016-03-31 | $1,235 |
| 2015-12-31 | $1,263 |
| 2015-09-30 | $1,278 |
| 2015-06-30 | $1,312 |
| 2015-03-31 | $1,227 |
| 2014-12-31 | $1,180 |
| 2014-09-30 | $1,288 |
| 2014-06-30 | $1,293 |
| 2014-03-31 | $1,327 |
| 2013-12-31 | $1,302 |
| 2013-09-30 | $1,307 |
| 2013-06-30 | $1,308 |
| 2013-03-31 | $1,289 |
| 2012-12-31 | $1,065 |
| 2012-09-30 | $1,109 |
| 2012-06-30 | $1,200 |
| 2012-03-31 | $1,062 |
| 2011-12-31 | $1,027 |
| 2011-09-30 | $988 |
| 2011-06-30 | $1,038 |
| 2011-03-31 | $1,018 |
| 2010-12-31 | $1,035 |
| 2010-09-30 | $1,009 |
| 2010-06-30 | |
| 2010-05-31 | $288 |
| 2010-03-31 | |
| 2010-02-28 | $243 |
| 2009-12-31 | $207 |
| 2009-11-30 | $208 |
| 2009-09-30 | |
| 2009-08-31 | $227 |
| 2009-05-31 | $252 |
| 2009-02-28 | $260 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.482B | $0.588B |
| Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $39.307B | 54.29 |
| Hims & Hers Health (HIMS) | United States | $13.112B | 136.23 |
| Tempus AI (TEM) | United States | $10.781B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.503B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.415B | 68.98 |
| Privia Health (PRVA) | United States | $3.036B | 207.50 |
| Enovis (ENOV) | United States | $2.041B | 11.38 |
| Clover Health Investments (CLOV) | United States | $1.735B | 0.00 |
| Schrodinger (SDGR) | United States | $1.706B | 0.00 |
| Phreesia (PHR) | United States | $1.529B | 0.00 |
| Omnicell (OMCL) | United States | $1.315B | 23.21 |
| Azenta (AZTA) | United States | $1.223B | 56.83 |
| 10x Genomics (TXG) | United States | $1.125B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.610B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.569B | 0.00 |
| Talkspace (TALK) | United States | $0.500B | 149.50 |
| Claritev (CTEV) | United States | $0.450B | 0.00 |
| Standard BioTools (LAB) | United States | $0.399B | 0.00 |
| TruBridge (TBRG) | United States | $0.368B | 816.67 |
| Health Catalyst (HCAT) | United States | $0.286B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.212B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.207B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.147B | 0.00 |
| Pulmonx (LUNG) | United States | $0.138B | 0.00 |
| American Well (AMWL) | United States | $0.117B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.090B | 0.00 |
| CareCloud (CCLD) | United States | $0.086B | 3.27 |
| Outset Medical (OM) | United States | $0.070B | 0.00 |
| 111 (YI) | China | $0.067B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.060B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.059B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.039B | 0.00 |
| Zhongchao (ZCMD) | China | $0.032B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.011B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Movano (MOVE) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |